Companies · Other Health Care
ST. PAUL · Other Health Care
Diligence memoA one-page analyst read on V Shareholder Investments INc. — recommendation, valuation, rhythm, risks.→V Shareholder Investments INc. looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
V Shareholder Investments INc. is one of 5377 Other Health Care companies tracked from ST. PAUL. By capital raised it ranks in the long tail (ahead of 38% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seed — a round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 38% of sector peers (real $). Modeled value above 22% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #199 of 295.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Aetas Co LLC | Pre-Seed | $1.0M | $30.8M | 3.80× |
| Hauppauge SC Holdings, LLC | Pre-Seed | $995K | $30.6M | 3.78× |
| Gateway IV Lithotripsy, LLC | Pre-Seed | $988K | $30.4M | 3.75× |
| Endoscopy Center of West Central Ohio, LLC | Pre-Seed | $964K | $29.7M | 3.66× |
| Dalent LLC | Pre-Seed | $1.9M | $29.2M | 3.61× |
| FK Investor LLC | Pre-Seed | $940K | $29.0M | 3.57× |
| Lynx Dx, Inc. | Pre-Seed | $925K | $28.5M | 3.51× |
| Center at Arrowhead, LLC | Pre-Seed | $918K | $28.3M | 3.49× |
| MedTek Valencia eCoin, LLC | Pre-Seed | $905K | $27.9M | 3.44× |
| Westside PetWell, LLC | Pre-Seed | $900K | $27.7M | 3.42× |
| Ulster Dialysis Partners, LLC | Pre-Seed | $930K | $27.6M | 3.40× |
| DoveMed, Ltd. | Pre-Seed | $1.5M | $26.5M | 3.27× |
| V Shareholder Investments INc. this company | Pre-Seed | $1.2M | $5.3M | 0.65× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | $917K | 2021-07-01 | $5.1M | $17.2M | 90% |
| Pre-Seed | $333K | 2021-11-01 | $1.8M | $5.3M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Paul Foley | — | 3 other | 2021-07 |
| Wendy Anne-Weingart Bennewitz | — | 1 other | 2021-07 |
| James Jorgenson | — | — | 2021-07 |
| Paul Flagstad | — | — | 2021-07 |
V Shareholder Investments INc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Visante, Inc. | Other Health Care | Pre-Seed | $1.2M | $3.7M | network1 shared operator · same sector · same stage |
| AdrenaCard Inc. | Other Health Care | Pre-Seed | $1.3M | $4.8M | same sector · same stage |
| Averify, LLC | Other Health Care | Pre-Seed | $1.3M | $5.4M | same sector · same stage |
| ProUroCare Medical Inc. | Other Health Care | Pre-Seed | $1.3M | $6.2M | same sector · same stage |
| Ocsc Inc | Other Health Care | Pre-Seed | $1.2M | $6.0M | same sector · same stage |
| NVOLVE, Inc. | Other Health Care | Pre-Seed | $1.3M | $5.0M | same sector · same stage |
| Myolyn, LLC | Other Health Care | Pre-Seed | $1.3M | $6.2M | same sector · same stage |
| Bladder Health Ventures, LLC | Other Health Care | Pre-Seed | $1.1M | $6.2M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| VVV Capital International LLP | Other Health Care | Seed | $83.7M | 86% |
| S&K Holdings, Inc. | Other Health Care | Seed | $47.0M | 85% |
| VPP Group Holdings, L.P. | Other Health Care | Seed | $6.8M | 85% |
| AVG Holdings, Inc. | Other Health Care | Series A | $282.5M | 85% |
| Vantage Holdings, Inc. | Other Health Care | Series D+ | $3.2B | 84% |
| C21 Investments Inc. | Other Health Care | Series A | $161.6M | 84% |
| Virginia Physician Holding Company, LLC | Other Health Care | Pre-Seed | $4.4M | 84% |
| Vyaire Holding Co | Other Health Care | Series B | $698.5M | 84% |
See where V Shareholder Investments INc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at V Shareholder Investments INc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.